Is DraftKings (DKNG) a Buy as Wall Street Analysts Look Optimistic?

DraftKings (DKNG) currently boasts a highly optimistic Average Brokerage Recommendation (ABR) of 1.27, indicating a strong buy consensus from 31 firms, with 80.7% rating it a "Strong Buy." However, the article advises caution against relying solely on ABRs due to inherent positive bias from brokerage firms' vested interests. The proprietary Zacks Rank, which prioritizes earnings estimate revisions, assigns DKNG a #3 (Hold) rating, supported by an unchanged consensus earnings estimate of $1.33 for the current year, suggesting a more measured approach despite the favorable ABR.

Analysis

DraftKings (DKNG) presents a conflicting profile for investors, characterized by a significant divergence between Wall Street sentiment and underlying earnings estimate momentum. On one hand, the stock has an exceptionally bullish Average Brokerage Recommendation (ABR) of 1.27 on a 1-to-5 scale, derived from 31 brokerage firms. This consensus includes 25 'Strong Buy' and three 'Buy' ratings, representing 90.4% of total recommendations. However, this optimism is tempered by a more cautious quantitative signal from the Zacks Rank, which assigns DKNG a #3 (Hold) rating. The basis for this neutral stance is the stagnation in earnings estimate revisions; the Zacks Consensus Estimate for the current year has remained unchanged at $1.33 over the past month. This lack of upward revision suggests analysts' views on near-term earnings prospects are steady but not improving, implying the stock may perform in line with the broader market rather than outperform as the ABR might suggest.

Key Decisions for Investors

• Investors should treat the overwhelmingly positive sell-side analyst consensus on DKNG with caution, as it is directly contradicted by the stagnant earnings estimate momentum, which points to a more neutral near-term outlook.
• Monitor upcoming earnings estimate revisions for DKNG closely, as any positive change to the current flat consensus of $1.33 would be a key catalyst required to validate the bullish analyst ratings.
• Given the mixed signals, it may be prudent to hold existing positions rather than initiate new ones, pending confirmation of improving earnings fundamentals that could justify the stock's strong buy consensus.